PROPANC BIOPHARMA, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $4.8M | $44.8K | — |
| Jun 2017 | $5.5M | $95.1K | — |
| Sep 2017 | $6.9M | $162.5K | — |
| Dec 2017 | $7.3M | $129.1K | — |
| Mar 2018 | $6.9M | $110.7K | — |
| Jun 2018 | $6.8M | $71.4K | — |
| Sep 2018 | $5.6M | $82.8K | — |
| Dec 2018 | $4.6M | $712.6K | — |
| Mar 2019 | $3.7M | $259.9K | — |
| Jun 2019 | $4.4M | $101.7K | — |
| Sep 2019 | $4.7M | $197.7K | — |
| Dec 2019 | $5.7M | $65.4K | — |
| Mar 2020 | $4.9M | $63.9K | — |
| Jun 2020 | $3.7M | $98.5K | $67.0K |
| Sep 2020 | $3.3M | $77.6K | — |
| Dec 2020 | $3.6M | $40.6K | — |
| Mar 2021 | $3.0M | $28.0K | $14.4K |
| Jun 2021 | $3.1M | $13.1K | $2.3K |
| Sep 2021 | $2.4M | $62.2K | $45.8K |
| Dec 2021 | $3.0M | $110.2K | $73.6K |
| Mar 2022 | $3.1M | $169.5K | $133.9K |
| Jun 2022 | $3.1M | $81.7K | $4.1K |
| Sep 2022 | $2.9M | $94.3K | $19.4K |
| Dec 2022 | $3.0M | $108.0K | $24.5K |
| Mar 2023 | $3.1M | $143.7K | $93.2K |
| Jun 2023 | $3.2M | $60.3K | — |
| Sep 2023 | $3.2M | $180.4K | — |
| Dec 2023 | $3.8M | $241.9K | — |
| Mar 2024 | $3.7M | $37.3K | — |
| Jun 2024 | $3.9M | $72.4K | — |
| Sep 2024 | $4.2M | $63.6K | — |
| Dec 2024 | $4.2M | $78.5K | — |
| Mar 2025 | $4.4M | $22.5M | — |
| Jun 2025 | $5.7M | $19.6M | — |
| Sep 2025 | $3.6M | $18.0M | — |
| Dec 2025 | $3.7M | $15.1M | — |
| Mar 2026 | $3.5M | $14.3M | — |